BOOSTERZ, a Korean startup and subsidiary of KOSDAQ-listed FSN, has closed a $25.4 million USD (37.4 billion KRW) RCPS investment round. The funding round brings BOOSTERZ’s total capital raised since inception to $43.3 million USD (63.7 billion KRW).

The investment was led by major institutional investors including SBI Investment, which previously invested $13.6 million USD (20 billion KRW) in December, along with Envestor, Lakebridge Equity Partners, and Hana Ventures.

This funding round represents significant market validation of BOOSTERZ’s competitive “K-brand symbiotic business model.” Rather than simply acting as an advertising agency, BOOSTERZ shares both marketing costs and results with partner brands, and even makes equity investments in brands with proven growth potential. While many advertising and marketing companies have entered the brand or commerce business, few have achieved substantial results. Growing brands requires both extensive know-how and specialized advertising marketing expertise that directly impacts performance.

This differentiated business model has already proven itself through impressive results. In just five years since its founding, BOOSTERZ achieved $68 million USD (100 billion KRW) in annual revenue and $6.8 million USD (10 billion KRW) in operating profit in 2024. The company projects record-breaking performance in 2025 with approximately $136 million USD (200 billion KRW) in revenue and $23.8 million USD (35 billion KRW) in operating profit. Accordingly, the company’s valuation has rapidly increased from approximately $68 million USD (100 billion KRW) in early last year to about $129.2 million USD (190 billion KRW) within one year. Based on this growth trajectory, BOOSTERZ has set a mid-to-long-term goal of achieving $340 million USD (500 billion KRW) in revenue and a valuation of $680 million USD (1 trillion KRW) within the next three years.

The newly secured investment will be strategically allocated toward additional equity investments in existing and new partner brands, expansion of the global K-brand ecosystem, and securing new growth engines. The company plans to significantly expand its business scope beyond its existing fashion and lifestyle portfolio into K-beauty and K-healthcare sectors.

BOOSTERZ plans to launch an innovative beauty brand during the first half of this year, partnering with a skincare company with neospicule-based technology to enter the K-beauty market. The company has also entered the domestic traffic accident and orthopedic patient platform market, estimated at approximately $1.7 billion USD (2.5 trillion KRW), by launching a new K-medical platform service called “Jeonghnadak.” Daedamo.com, a 100% subsidiary operating the hair loss community “Daedamo,” is also rapidly expanding global traffic to the United States, China, and Japan through multilingual services, continuing its success in the K-medical tourism sector. Along with revenue growth from platform businesses such as the wholly-owned Daedamo.com, BOOSTERZ continues stable growth on a standalone basis.

The company is also accelerating overseas expansion of its existing partner brands. Focusing on the Japanese market, BOOSTERZ has deployed localized content production, YouTuber collaborations, and offline promotions, resulting in notable monthly revenue growth within a short period while recording high ratings and repurchase rates, indicating meaningful overseas revenue contributions starting this year.

The K-beauty and K-healthcare markets that BOOSTERZ is expanding into are evaluated as sectors with significant mid-to-long-term growth potential. The K-beauty industry is rapidly growing, with Korean cosmetics exports exceeding $11 billion USD (approximately 16 trillion KRW) thanks to expanding global demand. The medical tourism market is also showing clear expansion, with the number of foreign patients surpassing 1 million. Expectations for BOOSTERZ’s future growth potential are particularly high given the high proportion of dermatology and plastic surgery in medical beauty, which offers strong synergies with K-beauty.

BOOSTERZ’s rapid growth and rising corporate value directly translate into potential revaluation opportunities for parent company FSN. As BOOSTERZ’s value and performance increase, FSN’s equity stake value is expected to expand accordingly, and BOOSTERZ’s revenue and operating profit growth is projected to lead to improvements in FSN’s consolidated performance and strengthening of its mid-to-long-term growth story.

Jeongkyo Seo, CEO of BOOSTERZ, stated, “We successfully secured this large-scale investment by gaining recognition for the growth potential and performance of BOOSTERZ’s symbiotic business model. Based on the secured funds, we will actively pursue strategic equity investments and global growth, and continue sustainable growth by creating high added value through expansion into high-growth sectors such as K-beauty and K-healthcare. Through this, BOOSTERZ will become a true booster that contributes to the growth of brands and platforms working with us, as well as substantially increasing FSN’s corporate value.”